ADLAI NORTYE

Chemico-pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders; injectable pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders; injectable pharmaceutical solutions for medical purposes for treatment of tumor, immune, and metabolic related diseases and disorders; troche, namely, medicated lozenges; medicines based on biologically active substances for treatment of tumor, immune, and metabolic related diseases and disorders; blood substitutes for medical and veterinary use; medicines for human purposes for treatment of tumor, immune, and metabolic related diseases and disorders; drugs for medical purposes for treatment of tumor, immune, and metabolic related diseases and disorders; biological preparations for medical purposes for treatment of tumor, immune, and metabolic related diseases and disorders; stem cells for medical purposes; biochemical drug, namely, biochemical pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders